USC News writes: “What if scientists could develop an opioid-based painkiller that is not addictive and has limited side effects? That is possible based on new findings by an international team of scientists that included contributions from top researchers at the USC Michelson Center for Convergent Bioscience … The findings were published Jan. 4 in the journal Cell. They are an example of how USC Michelson Center scientists collaborate with a range of experts in multiple disciplines to conduct groundbreaking research.” (January 4, 2018)